Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tanya M Potashnik"'
Autor:
Ambica Parmar, Vanessa Arciero, Erica Craig, Anthony Reiman, Darryl Boehm, Rebecca E Mercer, Kelvin K. W. Chan, Avram Denburg, Patricia Caetano, Jessica Arias, Barry Jones, Tanya M Potashnik, Pam Takhar, Wei Fang Dai, Elena R Lungu, Carole R Chambers, Jaclyn Beca, Mina Tadrous, Gunita Mitera, Nevzeta Bosnic, Trevor Ritcher, Brent Fraser
Publikováno v:
Current Oncology
Current Oncology, Vol 28, Iss 354, Pp 4174-4183 (2021)
Current Oncology, Vol 28, Iss 354, Pp 4174-4183 (2021)
The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration was established to develop a framework for generating and using real-world evidence (RWE) to inform the reassessment of cancer drugs following initial health techno
Autor:
Orlando J Manti, Mitchell Levine, Elena R Lungu, Tanya M Potashnik, Carol I McKinley, Douglas A Clark
Publikováno v:
Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique. 24(1)
Background Prescription drug expenditures represent a significant component of health care costs in Canada, with estimates of $28.8 billion spent in 2014. Identifying the major cost drivers and the effect they have on prescription drug expenditures a
Autor:
Tanya M. Potashnik, Malcolm Maclure
Publikováno v:
Canadian Public Policy / Analyse de Politiques. 23:132
Drug benefits policy-making for seniors in British Columbia has been increasingly influenced by research since 1993. The "evidence-based medicine" paradigm, which emphasizes the primacy of direct evidence from randomized control trials, inspired key